510(k) K220134

cobas pure integrated solutions, Glucose HK Gen.3, ISE indirect Na for Gen.2, ONLINE DAT Methadone II, Elecsys TSH by Roche Diagnostics — Product Code CFR

K220134 is an FDA 510(k) premarket notification submitted by Roche Diagnostics for the device "cobas pure integrated solutions, Glucose HK Gen.3, ISE indirect Na for Gen.2, ONLINE DAT Methadone II, Elecsys TSH". The FDA issued a decision of Substantially Equivalent on Sep 16, 2022. The device falls under product code CFR (Hexokinase, Glucose), a Class II device regulated under 21 CFR 862.1345. Roche Diagnostics has 456 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Sep 16, 2022
Date Received
Jan 18, 2022
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Hexokinase, Glucose
Device Class
Class II
Regulation Number
862.1345
Review Panel
CH
Submission Type
510(k)

Need the full FDA record for Roche Diagnostics? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K220134. Report a data issue: hello@regdatalab.com.